Compare Enveric Biosciences Inc (ENVB) vs MONDELEZ INTERNATIONAL INC Common Stock (MDLZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs MONDELEZ INTERNATIONAL INC Common Stock — how do they compare? Enveric Biosciences Inc trades at $1.35 (market cap $5.32M), while MONDELEZ INTERNATIONAL INC Common Stock trades at $59.96 (market cap $75.38B). The key difference: MONDELEZ INTERNATIONAL INC Common Stock is far larger — about 14169.2× Enveric Biosciences Inc's market cap, and MONDELEZ INTERNATIONAL INC Common Stock pays a 3.41% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | MDLZ | |
|---|---|---|
Market Cap | $5.32M | $75.38B |
Sector | Health | Consumer Staples |
52-Week High | $17.40 | $70.75 |
52-Week Low | $1.28 | $51.51 |
Enterprise Value | $408.82K | $95.47B |
Dividend Yield | — | 3.41% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Mondelez International (MDLZ) trades at $58.80, down 1.77% on the day, with a bearish technical signal despite recent earnings beats. The company maintains solid fundamentals with $38.54B revenue and 6.64% net margin in 2025, though profitability has moderated from 2023 peaks. Analyst consensus remains strongly bullish with a $68.00 price target, representing 15.6% upside potential. Recent developments include new CFO appointment and Q2 2026 earnings scheduled for July 28, 2026.
MDLZ presents a compelling value opportunity with strong brand portfolio and consistent execution, though near-term headwinds include cocoa price volatility and competitive pressures. The stock's current valuation at 29.07 P/E appears reasonable given growth prospects, while technical weakness may offer entry points for long-term investors seeking quality consumer staples exposure with dividend income.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About MONDELEZ INTERNATIONAL INC Common Stock
Mondelez has operated as an independent organization since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack arena with a presence in the biscuit (47% of sales), chocolate (32%), gum/candy (10%), beverage (4%), and cheese and grocery (7%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, Trident, and Cadbury, among others. The firm derives around one third of revenue from developing markets, nearly 40% from Europe, and the remainder from North America.
Read more on MDLZ →
